🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/07/1998 | 44,45 | 44,45 | 41,64 | 41,64 | -5,82% | 6,32% | 25.675 |
| 30/07/1998 | 43,98 | 44,92 | 43,04 | 44,21 | -1,56% | 4,26% | 20.705 |
| 29/07/1998 | 44,45 | 44,92 | 41,64 | 44,92 | +4,35% | 7,37% | 36.148 |
| 28/07/1998 | 44,45 | 45,85 | 42,11 | 43,04 | -4,17% | 8,42% | 27.331 |
| 27/07/1998 | 42,34 | 44,92 | 41,87 | 44,92 | +6,67% | 7,18% | 30.457 |
| 24/07/1998 | 45,38 | 45,38 | 41,64 | 42,11 | -6,25% | 8,25% | 24.633 |
| 23/07/1998 | 45,38 | 45,85 | 43,04 | 44,92 | +0,00% | 6,19% | 29.923 |
| 22/07/1998 | 44,92 | 45,85 | 44,92 | 44,92 | -1,03% | 2,08% | 42.506 |
| 21/07/1998 | 47,26 | 47,72 | 45,15 | 45,38 | -3,96% | 5,45% | 30.350 |
| 20/07/1998 | 47,72 | 47,96 | 46,32 | 47,26 | +1,51% | 3,43% | 38.151 |
| 17/07/1998 | 47,96 | 47,96 | 45,85 | 46,55 | -1,97% | 4,39% | 38.071 |
| 16/07/1998 | 48,42 | 48,42 | 47,49 | 47,49 | -1,93% | 1,93% | 12.263 |
| 15/07/1998 | 48,19 | 48,66 | 47,26 | 48,42 | +0,49% | 2,91% | 20.812 |
| 14/07/1998 | 48,19 | 49,59 | 48,19 | 48,19 | -2,37% | 2,91% | 20.599 |
| 13/07/1998 | 47,02 | 49,59 | 47,02 | 49,36 | +5,50% | 5,47% | 40.556 |
| 10/07/1998 | 47,26 | 49,13 | 46,79 | 46,79 | +0,50% | 4,95% | 59.258 |
| 09/07/1998 | 48,19 | 48,19 | 46,32 | 46,55 | -2,45% | 3,88% | 23.003 |
| 08/07/1998 | 47,26 | 48,19 | 46,32 | 47,72 | +2,51% | 3,96% | 29.228 |
| 07/07/1998 | 46,55 | 47,49 | 46,55 | 46,55 | -1,49% | 2,01% | 54.502 |
| 06/07/1998 | 46,32 | 47,72 | 45,85 | 47,26 | +0,50% | 4,04% | 25.888 |
| 02/07/1998 | 46,79 | 48,19 | 46,32 | 47,02 | -0,99% | 4,00% | 20.091 |
| 01/07/1998 | 47,72 | 48,19 | 46,79 | 47,49 | -1,46% | 2,94% | 44.029 |
| 30/06/1998 | 49,13 | 49,13 | 46,79 | 48,19 | +0,98% | 4,76% | 48.384 |
| 29/06/1998 | 49,13 | 49,13 | 46,79 | 47,72 | -1,92% | 4,76% | 43.628 |
| 26/06/1998 | 47,72 | 49,59 | 47,26 | 48,66 | +2,97% | 4,90% | 39.541 |
| 25/06/1998 | 48,19 | 49,13 | 47,26 | 47,26 | -3,81% | 3,88% | 18.622 |
| 24/06/1998 | 47,72 | 49,13 | 47,72 | 49,13 | +0,96% | 2,94% | 15.923 |
| 23/06/1998 | 49,13 | 49,13 | 47,26 | 48,66 | +1,96% | 3,81% | 40.850 |
| 22/06/1998 | 47,72 | 48,19 | 46,55 | 47,72 | -0,97% | 3,43% | 31.552 |
| 19/06/1998 | 47,26 | 48,42 | 47,26 | 48,19 | +1,48% | 2,48% | 12.076 |